2024 Spain Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

Publisher Name :
Date: 21-Jul-2020
No. of pages: 1117

This new 1,117-page report from LeadingMarketResearch.com contains 55 tables.

The report is available by section, and can be customized to specific information needs and budget. The report presents comprehensive analysis of the Spanish molecular diagnostics market, including:

  • Major issues pertaining to the Spanish molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Ten-year test volume and reagent sales forecasts for the following categories:
   -   Infectious Diseases Genetic Diseases

   -  Cancer

   -   Paternity Testing/HLA Typing

   -   Forensic Testing

  • Review of testing methodologies an instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.
Contains 1,117 pages and 55 tables

2024 Spain Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

Table of Contents

I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing
Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Market and Technology Review
A. DNA Sequencing
1. Introduction
2. Sequencing Methods
3. Autoradiography
4. The Human Genome Project
5. Sequencing Automation
6. Image Scanners
7. Fluorescent Detection
8. Gene Profiling
9. Gene Expression
10. Polymorphism Screening
11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
1. Basic Principles
2. Probe Preparation
3. The DNA Probe Test
4. Test Formats
5. Labeling Techniques
6. Amplification Methods
C. Detection Technologies
1. Radioactive Methods
2. Non-Isotopic Methods
D. Instrumentation
Review of latest analyzers from Abbott, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Hologic, Qiagen, Roche, ??????Siemens Healthineers, and others.
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
F. Pharmacogenomics
G. Major Applications
1. Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
° AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
° Adenovirus
° Aeromonas
° Anthrax/Bacillus Anthracis
° Arboviruses
° Babesiosis
° Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
° Blastocystis Hominis
° Brucella
° Campylobacter
° Candida
° Chagas Disease
° Chancroid
° Chlamydia
° Clostridium Difficile
° Coronaviruses
° Coxsackieviruses
° Creutzfeldt-Jakob's Disease
° Cryptosporidium Parvum
° Cyclospora Cayetanensis
° Cytomegalovirus
° Ebola Virus
° E. Coli
° EchoVirus
° Encephalitis
° Enteroviruses
° Epstein-Barr Virus
° Giardia Lamblia
° Gonorrhea
° Granuloma Inguinale
° Hantavirus
° Helicobacter Pylori
° Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
° Herpes Simplex Virus
° Human Herpes Virus-6 (HHV-6)
° Influenza Viruses
° Legionella
° Lyme Disease
° Lymphogranuloma Venereum (LGV)
° Malaria
° Measles (Rubeola)
° Meningitis
° Microsporidium
° Mononucleosis
° Mumps
° Mycoplasma
° Papillomaviruses
° Parvovirus B19
° Pneumonia
° Polyomaviruses
° Pseudomonas Aeruginosa
° Rabies
° Respiratory Syncytial Virus (RSV)
° Rhinoviruses
° Rotavirus
° Rubella
° Salmonellosis
° Septicemia
° Shigellosis
° Staphylococcus Aureus
° Streptococci
° Syphilis
° Toxoplasmosis
° Trichomonas Vaginalis
° Tuberculosis
° Vibrio
° West Nile Virus
° Yersina
2. Cancer Testing
a. Overview
b. Major Cancer Types
* Prostate
* Lung
* Colon and Rectum
* Breast
* Skin
* Uterine
* Leukemia
* Oral
c. Oncogenes
The report provides review of both current and emerging oncogenes, including:
O Abl/abl-bcr
O AIB1
O BCL-2
O BRCA1
O CD44
O C-fos
O C-myb
O C-myc
O CYP17
O Erb-B
O HPC1
O N-myc
O P40
O P51
O P53
O PIK3CA
O PTI-1
O Ras
O Reg
O Sis
O Src
3. Genetic Diseases
a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
* Achondroplasia
* Autosomal Dominant Polycystic Kidney
Disease
* Cancer
* Cosmetogenomics
* Cystic Fibrosis
* Down's Syndrome
* Duchenne and Becker Muscular Dystrophy
* Factor V (Leiden)
* Factor IX Deficiency
* Fragile X Syndrome
* Heart Disease
* Hemochomatosis
* Hemophilia
* Huntington's Disease
* Maternal-Fetal Incompatibility
* Multiple Endocrine Neoplasia
* Phenylketonuria (PKU)
* Polycystic Kidney Disease (PKD)
* Prenatal Screening
* Retinitis Pigmentosa
* Retinoblastoma
* Sickle Cell Anemia
* Spinal Muscular Atrophy
* Vitamin B12 Metabolism
i. Social Issues and Concerns
4. Forensic Testing
a. Overview
b. Multilocus and Single Locus Probes
c. The FBI
d. DNA Profile Data Banks
e. Judicial Implementation
f. Major Crime Categories
g. Factors Contributing to the DNA Probe
Market Expansion
h. Wildlife Forensics
5. Paternity Testing/HLA Typing
6. Other Applications
a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimer's Disease
e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. W ater Contamination
i. Other
H. Competing/Complementing Technologies
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two-Dimensional Electrophoresis
4. Flow Cytometry
VII. Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
VIII. Competitive Assessments
The report provides strategic assessments of over 40 leading molecular diagnostics
market players and start-up companies with innovative technologies and products, including:
Abbott, Agilent Technologies, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, DiaSorin, Eiken Chemical, Enzo, Fujirebio, Grifols, Hologic, Illumina, LabCorp/Sequenom, Leica Biosystems, Myriad Genetics, Ortho-
Clinical Diagnostics, Qiagen, Quest Diagnostics, Quidel, Roche, Shimadzu, Siemens Healthineers, Sierra Molecular, Takara Bio, Tecan Group, Thermo Fisher, Wako and others.

List of Tables

Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
Spain Molecular Diagnostics Test Volume And Sales by Major Application
Spain Laboratories Performing DNA Sequencing by Market Segment
Spain Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Spain Molecular Diagnostics Test Volume by Major Application
Spain Major Infectious Disease Test Volume by Assay
Spain Major Infectious Disease Test Volume by Method
Spain Molecular Diagnostics Market by Major Application
Spain Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Spain Major Infectious Disease Diagnostics Market by Assay
Spain AIDS Testing Market Estimated Sales by Major Supplier
Spain Chlamydia Testing Market Estimated Sales by Major Supplier
Spain CMV Testing Market Estimated Sales by Major Supplier
Spain Gonorrhea Testing Market Estimated Sales by Major Supplier
Spain Hepatitis Testing Market Estimated Sales by Major Supplier
Spain Hepatitis C Testing Market Estimated Sales by Major Supplier
Spain HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Spain Herpes Testing Market Estimated Sales by Major Supplier
Spain Influenza Testing Market Estimated Sales by Major Supplier
Spain Meningitis Testing Market Estimated Sales by Major Supplier
Spain Mycoplasma Testing Market Estimated Sales by Major Supplier
MySQL server has gone away